Vaccination strategies for control of community outbreaks of hepatitis A: A comparison of two outbreaks in England.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
07 03 2019
Historique:
received: 08 09 2017
revised: 08 01 2019
accepted: 10 01 2019
pubmed: 17 2 2019
medline: 5 8 2020
entrez: 17 2 2019
Statut: ppublish

Résumé

In August 2015 two community outbreaks of hepatitis A virus (HAV) occurred in sub-urban communities in Northern England. Each was managed by an independent outbreak control team. In outbreak one, mass vaccination was deployed targeting a residential area and two schools, while in outbreak two, vaccination was reserved for household-type contacts of cases. The highest vaccination uptake was achieved in the school settings (82% and 95%). These case studies illustrate the range of approaches that can be used and the factors that influence decision-making in response to a hepatitis A community outbreak. Both outbreaks likely started from importation(s) of HAV by returning travellers and spread through extended social networks and the local community. Vaccination strategies were selected based on hypotheses about transmission pathways, which were informed by evidence from oral fluid (OF) testing of asymptomatic contacts. More evidence about the effectiveness of mass vaccination in community outbreaks of hepatitis A in low endemicity settings is needed. Hepatitis A guidelines should include recommendations for the use of mass vaccination and OF testing in outbreaks.

Identifiants

pubmed: 30770222
pii: S0264-410X(19)30089-1
doi: 10.1016/j.vaccine.2019.01.026
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1521-1527

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Auteurs

Ashley Sharp (A)

Health Protection Team, Public Health England North West, Manchester, UK. Electronic address: Ashley.sharp@phe.gov.uk.

Suzi Coles (S)

Health Protection Team, Public Health England Yorkshire and the Humber, Leeds, UK.

Matthieu Pegorie (M)

Health Protection Team, Public Health England North West, Manchester, UK.

Ceryl Harwood (C)

Health Protection Team, Public Health England Yorkshire and the Humber, Leeds, UK.

Siew-Lin Ngui (SL)

Virus Reference Unit, National Infection Service, Public Health England, London, UK.

William Welfare (W)

Health Protection Team, Public Health England North West, Manchester, UK; Manchester Academic Health Science Centre, University of Manchester, UK.

Sema Mandal (S)

Centre of Infectious Disease Surveillance and Control, National Infection Service, Public Health England, London, UK.

Koye Balogun (K)

Centre of Infectious Disease Surveillance and Control, National Infection Service, Public Health England, London, UK.

Mike Gent (M)

Health Protection Team, Public Health England Yorkshire and the Humber, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH